# A Study of JNJ-61393215 in Healthy Japanese Male Participants

> **NCT04713930** · PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-61393215
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04713930
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-29
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04713930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04713930, "A Study of JNJ-61393215 in Healthy Japanese Male Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04713930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*